Literature DB >> 18443790

Vitamin D receptor genotypes and response to zoledronic acid therapy in thalassemia-induced osteoporosis.

Zaher K Otrock, Rami A Mahfouz, Khalil M Charafeddine, Roni F Rayes, Laila F Zahed, Ali T Taher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18443790     DOI： 10.1007/s00277-008-0497-5

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  3 in total

Review 1.  Bone recovery after zoledronate therapy in thalassemia-induced osteoporosis: a meta-analysis and systematic review.

Authors:  M Mamtani; H Kulkarni
Journal:  Osteoporos Int       Date:  2009-02-26       Impact factor: 4.507

2.  Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis.

Authors:  Johann D Ringe
Journal:  Patient Prefer Adherence       Date:  2010-07-21       Impact factor: 2.711

3.  Genetic Polymorphisms Analysis of Pharmacogenomic VIP Variants in Miao Ethnic Group of Southwest China.

Authors:  Tianbo Jin; Ainiwaer Aikemu; Mingxi Zhang; Tingting Geng; Tian Feng; Longli Kang; Man Lin Luo
Journal:  Med Sci Monit       Date:  2015-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.